Connect with key
biotech players from
across Central Europe

Hannah leads the bioscience team and works with university inventors to commercialize their research. With the help of programs developed by Venture Partners, The University of Colorado Boulder has seen a record of 35 new startups in 2024, the second most by any U.S. university ever. Hannah has over a decade of experience in strategic licensing and IP management in life sciences from various U.S. institutions and holds a Ph.D. in Microbiology from The University of Texas at Austin.

Title of the talk: Hannah will share how the team grew its inventor-founder friendly resources that enabled many university inventors to embrace the entrepreneurial path.

Investor Panel Discussion

Representatives from VC funds and investment vehicles of major companies actively investing in Life Sciences in the CEE region will discuss current trends and share their recommendations for early-stage companies.

The panelists are:

David Flores, CEO, BioCentury
Ingrid Kelly, Partner, xista science ventures
Marek Tyl, Business Development Manager Europe, Eppendorf SE
John Murray, VP Global Business Development, SanaClis

Who could give you better advice than those who have been in your shoes? Executives from emerging companies in the region will share their experiences from the early days of their start-up journey and offer insights on how to survive and thrive.

The third panel discussion will explore the timely and evolving impact of AI in drug discovery. Chaired by Chris Tame, CEO of TernaryTx, the panel will feature diverse perspectives from leaders across the ecosystem – including a major pharmaceutical company, an early-stage biotech, a venture investor, and a legal expert.

The future lies in integrating advanced data management platforms that simplify collaboration, ensure data integrity, and support faster decision-making. This is exactly where platforms like CDD Vault come in—streamlining workflows and enabling scientists to focus on discovery rather than data wrangling.

Antima Gupta, PhD. is an Application Scientist in the technical support team at Collaborative Drug Discovery based in the UK. With a decade of experience at the intersection of biological research and data science, she is dedicated to advancing the scientific community through the implementation of best practices in data management and the development of intuitive, streamlined workflows. Her dynamic, client-focused approach is underscored by a proven ability to tackle complex technical challenges with precision and clarity. She holds a PhD in Molecular Microbiology, where her research centered on high-throughput drug discovery for neglected diseases. 

​

Workshop unpack key legal principles around employee inventions, disclosure procedures, and rights of universities versus researchers.

Diana Urbášková is a Czech attorney specializing primarily in biotech spin-offs, licensing, and technology transfer. She supports innovation by drafting various agreements and advising on intellectual property, corporate governance, and legal aspects of company formation and growth within research and biotech sectors.

Edita Bobčíková is a Czech lawyer specializing in corporate governance, IP, and legal support for startups. She supports innovative companies in navigating regulatory challenges and protecting their business interests, with a focus on growth and strategic development.

​